Sherratt, S., & Mason, R. (2018). Eicosapentaenoic acid inhibits oxidation of high density lipoprotein particles in a manner distinct from docosahexaenoic acid. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2018.01.062 (Original work published 2018)

Zhou, H., Arias-Ramos, N., López-Larrubia, P., Mason, R., Cerdán, S., & Pacheco-Torres, J. Oxygenation Imaging by Nuclear Magnetic Resonance Methods. Methods in Molecular Biology (Clifton, N.J.), 1718, 297-313. https://doi.org/10.1007/978-1-4939-7531-0_18 (Original work published 2018)

Borow, K., Mason, R., & Vijayaraghavan, K. (2017). Eicosapentaenoic Acid as a Potential Therapeutic Approach to Reduce Cardiovascular Risk in Patients with End-Stage Renal Disease on Hemodialysis: A Review. Cardiorenal Medicine, 8(1), 18-30. https://doi.org/10.1159/000479391

Sherratt, S., & Mason, R. (2018). Eicosapentaenoic acid and docosahexaenoic acid have distinct membrane locations and lipid interactions as determined by X-ray diffraction. Chemistry and Physics of Lipids. https://doi.org/10.1016/j.chemphyslip.2018.01.002 (Original work published 2018)

Verma, S., Bhatt, D., Steg, P., Miller, M., Brinton, E., Jacobson, T., … REDUCE-IT, I. (2021). Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG. Circulation, 144(23), 1845-1855. https://doi.org/10.1161/CIRCULATIONAHA.121.056290 (Original work published 2021)